“It really hits home for me because I’m a former prosecutor and I’ve worked with the California Highway Patrol—they have the most amazing men and women,” said Bobby Taghavi, Managing Partner and former prosecutor at Sweet James. “It was important for Sweet James to partner with them to give back to the community and to… Continue reading Sweet James, partners with KCAL News to Donate Thousands of Dollars in Toys to Chips For Kids led by Managing Partner and Former Prosecutor, Bobby Taghavi
Tag: M and A
Hero MotoCorp extends tie-up with Harley-Davidson for new motorcycle
India’s largest two-wheeler maker Hero MotoCorp has extended its partnership with US-based premium motorcycle maker Harley-Davidson Motor to co-develop and manufacture a new motorcycle as well as expand the existing co-developed model – X440 – into new variants. Hero MotoCorp and Harley-Davidson have been collaborating since 2020 to co-develop and sell premium motorcycles for India… Continue reading Hero MotoCorp extends tie-up with Harley-Davidson for new motorcycle
KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, Dec. 28, 2024 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) common stock pursuant and/or traceable to Kyverna’s registration statement issued in connection with Kyverna’s initial public offering (“IPO”) held on February 8, 2024, have until Friday, February 7, 2025 to seek appointment… Continue reading KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
NEW YORK, Dec. 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), of the important February 10, 2025 lead plaintiff deadline. So what: If you purchased… Continue reading SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
How Osamu Suzuki redefined the art of frugal manufacturing
Frugal engineering became a fashionable term thanks largely to Carlos Ghosn, the former CEO of Renault-Nissan. However, it was the late Osamu Suzuki who truly was the father of frugality which he practised with relentless passion for decades at Suzuki Motor Corporation. The kind of costing efficiencies generated as a result helped this small carmaker… Continue reading How Osamu Suzuki redefined the art of frugal manufacturing
JSW Energy to buy O2 Power’s 4.7 GW renewable energy platform for Rs 12,468 cr
JSW Energy Ltd will acquire a 4,696 MW renewable energy platform from O2 Power Pooling Pte Ltd for an enterprise value of Rs 12,468 crore, marking the energy major’s largest acquisition The acquisition will be made through its wholly-owned subsidiary, JSW Neo Energy Ltd. Sweden-based EQT Infrastructure and Singapore’s Temasek jointly established the renewable energy… Continue reading JSW Energy to buy O2 Power’s 4.7 GW renewable energy platform for Rs 12,468 cr
PACS GROUP SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against PACS Group, Inc. – PACS
NEW ORLEANS, Dec. 27, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 13, 2025 to file lead plaintiff applications in securities class action lawsuits against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company’s a) securities between April 11, 2024 and November 5,… Continue reading PACS GROUP SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against PACS Group, Inc. – PACS
KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. – KYTX
NEW ORLEANS, Dec. 27, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 7, 2025 to file lead plaintiff applications in a securities class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NasdaqGS: KYTX), if they purchased the Company’s shares pursuant and/or traceable to the Company’s… Continue reading KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. – KYTX
CAPRI HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Capri Holdings Limited – CPRI
NEW ORLEANS, Dec. 27, 2024 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against Capri Holdings Limited (the “Company”) (NYSE: CPRI), if they purchased… Continue reading CAPRI HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Capri Holdings Limited – CPRI
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
CRANFORD, N.J., Dec. 27, 2024 /PRNewswire/ — Citius Oncology, Inc. (“Citius Oncology” or the “Company”) (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024. Fiscal Full Year 2024 Business Highlights and Subsequent… Continue reading Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update